Anti-Human OX40L Antibodies
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 9 of these applications claim priority to application PCT/GB2015/050614, filed Mar 3, 2015. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,512,229 | Synergistic Combinations of OX40L Antibodies for the Treatment of GVHD In force · High confidence | Kymab Limited | In force | High confidence | ||
| US 9,587,030 | Anti-hOX40L Antibodies, Uses, & Methods In force · High confidence | Kymab Limited | In force | High confidence | ||
| US 9,868,789 | Synergistic Combinations of OX40L Antibodies for the Treatment of GVHD In force · High confidence | Kymab Limited | In force | High confidence | ||
| US 9,868,790 | Synergistic Combinations of OX40L Antibodies for the Treatment of GVHD In force · High confidence | Kymab Limited | In force | High confidence | ||
| US 10,654,935 | Methods of Treating Sle with ANTI-OX40L Antibodies In force · High confidence | Kymab Limited | In force | High confidence | ||
| US 10,669,342 | ANTI-OX40L Antibodies and Methods of Treating Graft Versus Host Disease In force · High confidence | Kymab Limited | In force | High confidence | ||
| US 11,396,550 | Methods of Treating Comprising Administering ANTI-OX40L Antibodies In force · High confidence | Kymab Limited | In force | High confidence | ||
| US 11,753,479 | Nucleic Acids Encoding ANTI-OX40L Antibodies In force · High confidence | Kymab Limited | In force | High confidence | ||
| US 11,773,175 | Antibodies, Uses & Methods In force · High confidence | Kymab Limited | In force | High confidence | ||
| US RE50,880 | Anti-Human OX40L Antibodies and Methods of Treatment In force · Low confidence | Kymab Limited | In force | Low confidence | ||
| 9 more patents in this group · Pro | ||||||
10 of 19 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 19, including 1 expired.
12 of these are in force and held by Kymab Limited.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.